The companys increased R&D investmentup 48% underscores its commitment to clinical innovation and expanding product indications
Most of the tools for managing it are already within reach
"In cases where glutathione demands are high, or there are genetics inhibit glutathione production, glutathione supplementation is often very effective." Taking glutathione itself is problematic because it is a peptide, and peptides break down in the digestive system
In many disease states, such as metabolic syndrome, inflammatory bowel disease (IBD), cardiovascular diseases, malignant tumors, etc., the structure and function of intestinal microbiota are obviously different from those of healthy bowel microbiota (Tilg and Moschen, 2014
Some patients choose to use the cutting edge medications semaglutide and/or Tirzepatide, which work by mimicking the GLP-1 hormone